Predicting Outcomes in Laryngeal Cancer with p53, PCNA, and Ki-67
Author Information
Author(s): Sarafoleanu D, Postelnicu V, Iosif C, Manea C, Sarafoleanu C
Primary Institution: ‘Sfanta Maria’ Clinical Hospital, ENT–HNS Department, Bucharest, Romania
Hypothesis
The study aims to determine the importance of p53, PCNA, and Ki-67 as outcome predictors in laryngeal carcinoma treatment.
Conclusion
The study found that high levels of p53, PCNA, and Ki-67 are correlated with poor differentiation and worse survival outcomes in laryngeal cancer patients.
Supporting Evidence
- High values of p53, PCNA, and Ki-67 are associated with poor differentiation in laryngeal carcinomas.
- Patients with well-differentiated tumors had a survival rate of 90%.
- Patients diagnosed in advanced TNM stages had lower survival rates.
Takeaway
Doctors can use certain markers in laryngeal cancer to predict how well a patient will do after treatment.
Methodology
A retrospective study analyzing immunohistochemical markers in 71 patients with laryngeal carcinoma who underwent surgery.
Limitations
The study is limited to a retrospective analysis and may not account for all variables affecting outcomes.
Participant Demographics
Patients aged 35 to 71, with 90.1% being men.
Statistical Information
P-Value
p<0.001
Confidence Interval
95%
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website